MedPath

MRI in Assessing Tumor Size in Women With Ductal Carcinoma In Situ

Not Applicable
Completed
Conditions
Breast Cancer
Interventions
Procedure: magnetic resonance imaging
Procedure: radiomammography
Procedure: ultrasound imaging
Registration Number
NCT00874458
Lead Sponsor
Centre Antoine Lacassagne
Brief Summary

RATIONALE: Diagnostic procedures, such as MRI, may help find ductal carcinoma in situ and find out how far the disease has spread.

PURPOSE: This clinical trial is studying how well MRI works in assessing tumor size in women with ductal carcinoma in situ.

Detailed Description

OBJECTIVES:

Primary

* Assess the contribution of MRI in accurately determining tumor size in women with ductal breast carcinoma in situ (DCIS).

Secondary

* Evaluate the sensitivity of MRI in detecting DCIS.

* Evaluate the contribution of mammography in accurately determining tumor size.

* Compare the contribution of MRI vs mammography in assessing tumor extension.

* Compare the contribution of MRI vs mammography in assessing dense breasts.

* Evaluate the morphology of DCIS by MRI.

* Evaluate the curve of dynamic MRI in assessing DCIS.

* Evaluate the impact of nuclear grade of DCIS by MRI.

* Evaluate the rate of revision surgery.

OUTLINE: Patients undergo clinical examination, mammography, ultrasound imaging, unilateral breast MRI, and tissue sampling.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
40
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
MRIultrasound imaging-
MRImagnetic resonance imaging-
MRIradiomammography-
Primary Outcome Measures
NameTimeMethod
Correlation of tumor extension by MRI with surgical histologyup to 1 year
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Centre Antoine Lacassagne

🇫🇷

Nice, France

© Copyright 2025. All Rights Reserved by MedPath